近日，英国剑桥大学的科学家们成功进行了一项基于CRISPR新型基因疗法的首次治疗试验。此次试验的对象是10名患有罕见炎症疾病遗传性血管性水肿的患者。试验结果显示，其中9名患者几乎痊愈。这一成果标志着新基因疗法在治愈危险炎症疾病方面取得了重要突破。
研究人员通过对患者进行基于CRISPR的基因编辑治疗，成功修复了导致炎症的基因缺陷。这种新型基因疗法有望为众多炎症疾病患者带来新的治疗希望。试验成果于2月1日发表在《新英格兰医学杂志》上，引起了广泛关注。
英文翻译：
News title: Gene editing therapy helps cure inflammatory diseases
Keywords: Gene editing, Inflammatory diseases, Cure experiment
News content:
Recently, scientists at the University of Cambridge successfully conducted the first treatment trial of a novel gene therapy based on CRISPR. The trial targeted 10 patients suffering from the rare inflammatory disease hereditary angioedema. The results showed that nearly all patients (9 out of 10) were cured. This indicates that the new gene therapy holds promise for treating dangerous inflammatory diseases. The research was published in the New England Journal of Medicine on February 1, attracting widespread attention.
【来源】http://www.chinanews.com/life/2024/02-04/10158474.shtml
Views: 1